Rosebud Biosciences
Growing micro-organs to find new drugs
Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.
- Website
- rosebudbiosciences.com
- City
- San Francisco
- Country
- United States
- YC batch
- Winter 2022
- Team
- 3 people
- Stage
- Early stage
- AI-native
- No
More Health & bio in San Francisco
Innovaccer$1.3bn
Indian digital healthcare company.
Thatch$1bn
Health benefits. Valued at $1bn (September 2026).
Chan Zuckerberg BiohubLab
Nonprofit research network building virtual cell models.
AthelasHiring
Extensible, Integrated Technology that Simplifies Health Systems
ClipboardHiring
Every shift, Covered.
Benchling
Unlocking the power of biotech with modern software for modern science
Claim this profile
Free and instant: prove you run rosebudbiosciences.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Rosebud Biosciences across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Rosebud Biosciences's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
